Status:
COMPLETED
Monolaurin Ointment Versus Mupirocin Ointment
Lead Sponsor:
Victoriano Luna Medical Center
Conditions:
Bacterial Infections
Eligibility:
All Genders
5-18 years
Phase:
EARLY_PHASE1
Brief Summary
Skin infection remains one of the leading causes of pediatric consults especially in developing countries like the Philippines. This common condition has not been considered a significant problem that...
Detailed Description
The advanced technology of modern science aims to formulate a new class of antibiotics due to the emergence of antibiotic resistance in microorganisms becoming a concerning threat in the medical commu...
Eligibility Criteria
Inclusion
- Subject aged 5 years old to 18 years old (school-aged children)
- Subjects has infected wound (laceration, sutured wound or abrasion), impetigo and other bacterial skin infections (positive gram stain or culture)
- Subject has total skin infection rating scale score of at least 4 including pus/exudate score of at least 1
- Subject parent/legal guardian is willing and able to comply with protocol (see attached consent)
- Subject parent/legal guardian has given written informed consent or assent as applicable.
- Patient has good hygiene
Exclusion
- Previous hypersensitivity to Mupirocin
- Secondary- infected animal/human bite or punctured wound
- Subject has a large draining abscess
- Chronic ulcerative lesion
- Other underlying skin disease
- Patient is severely malnourished
- Systemic signs and symptoms of infection
- Infection not to be appropriately treated with topical antibiotic
- Infections requires surgical intervention prior to study
- Subject received systemic antibacterial or steroid, or topical therapeutic agent within 24 hours of entry into study
- Serious underlying medical conditions/ diseases (diabetes mellitus)
- Other investigational drug within 30 days of study entry.
Key Trial Info
Start Date :
June 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 15 2023
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06046937
Start Date
June 1 2023
End Date
July 15 2023
Last Update
October 17 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
V. Luna Medical Center
Quezon City, NCR, Philippines, 1110